Minimal residual disease assessment in acute lymphoblastic leukemia by 4-color flow cytometry: Recommendations from the MRD Working Group of the Brazilian Society of Bone Marrow Transplantation Maura R.V. Ikoma-Colturato, Miriam P. Beltrame, Felipe M. Furtado, Glicinia Pimenta, Elaine Sobral da Costa, Ana Paula Azambuja, Mariester Malvezzi, Mihoko Yamamoto

Immunophenotypic markers for the evaluation of minimal/measurable residual disease in acute megakaryoblastic leukemia Carina Maria Pinto, Camila Marques Bertolucci, Alef Rafael Severino, Juliana Fernanda dos Santos Tosi, Maura R V Ikoma-Colturato

MINIMAL RESIDUAL DISEASE DETECTED BY FLOW CYTOMETRY AS A TOOL FOR RISK STRATIFICATION IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA IN THERAPY ACCORDING TO BFM 2009 ADAPTED PROTOCOL AB Gouveia, ER Biojone, RM Pontes, R Camargo, ACMDS Junior, PO Magalhães, FM Furtado